Skip to main content

Table 1 Summary of the 63 included studies

From: Associations between BRAFV600E and prognostic factors and poor outcomes in papillary thyroid carcinoma: a meta-analysis

Study Ethnic A: Asia C: Caucasia PTC number positive/negative BRAFV600E mutation rate, %
O'Neill [26] A 85/22 79.4
Daliri [65] A 28/41 40.6
Han [51] A 353/146 70.7
HE [59] A 119/68 63.6
Namba [28] A 26/14 65.0
Ahn [27] A 38/88 30.2
Hong1 [61] A 120/73 62.2
Hong2 [61] A 1792/639 73.7
Liu [12] A 213/126 62.8
Jung [36] A 162/48 77.1
Kim [41] A 64/15 81.0
Kim [7, 43] A 34/69 33.0
Kim [7] A 149/54 73.4
Kim [66] A 265/57 82.3
LEE [16] A 58/42 42.0
Lee [9] A 24/40 37.5
Lim [54] A 2219/728 75.3
Liu [40] A 47/54 46.5
Liu [12] A 80/52 60.6
Rivera [42] A 43/18 70.5
Khan [56] A 15/45 25
Shao [58] A 133/67 66.5
Wang [57] A 80/35 69.6
Lee [16] A 241/390 38.4
Puxeddu [22] A 281/485 36.4
Yim [50] A 123/41 75
Jo [44] A 102/59 63.4
Zeng [62] A 465/154 75.1
Henke [67] A and C 340/168 66.9
Czarniecka [64] C 38/50 43.2
Abrosimov [34] C 23/17 57.5
Alzahrani [47] C 96/185 34.2
Guerra [48] C 90/78 53.6
Frasca [25] C 60/41 59.4
Ahn [27] C 217/286 45.4
Durante [20] C 56/37 60.2
Nikiforova [21] C 24/36 40.0
Frasca [25] C 125/198 38.7
Fugazzola [8] C 99/161 38.1
Basolo [32] C 472/575 45.1
Basolo [32] C 229/349 39.6
Oler [49] C 48/25 65.8
Howell [14] C 86/133 39.3
Nakayama [29] C 173/124 58.2
Fernandez [30] C 153/143 51.7
Fugazzola [6] C 18/29 38.3
Lee [69] C 44/19 70
Li [55] C 297/91 76.5
Yip [39] C 99/100 49.7
Jung [36] C 19/24 44.2
Durante [20] C 38/66 36.5
Howell [14] C 15/40 27.3
Pelizzo [35] C 98/43 69.5
McKelvie [68] C 45/22 67.2
Riesco [37] C 28/39 41.8
Ito [23] C 38/64 37.3
Russo [60] C 57/46 55.3
Ulisse [45] C 44/47 48.4
Sykorova [63] C 81/161 33.5
Musholt [46] C 122/168 42.1
Angell [53] C 16/17 48.9
Xing [18] C 107/112 48.9
Xing [19] C 73/117 40.6
Xing [52] C 194/313 38.3
Xing [1, 10] C/A 845/1004 45.7